FABP1 offers superior characteristics regarding tissue distribution and kinetics compared to ALT (Table 3), and it is involved in numerous metabolic disease processes, including those of liver disease, cancer, diabetes, obesity, and atherosclerosis. This evidence concerns the gene FABP1 and liver disorder.